Your browser doesn't support javascript.
loading
Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi-institutional study.
Okada, Rei; Otsuka, Yuichiro; Yokosuka, Osamu; Kato, Naoya; Imazaki, Fumio; Hoshino, Isamu; Sugiura, Nobuyuki; Mizumoto, Hideaki; Azemoto, Ryousaku; Kato, Kazuki; Shimada, Hideaki.
Afiliación
  • Okada R; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
  • Otsuka Y; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
  • Yokosuka O; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8677, Japan.
  • Kato N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8677, Japan.
  • Imazaki F; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8677, Japan.
  • Hoshino I; Department of Surgery, Chiba Cancer Center, Chiba-shi, Chiba 260-8717, Japan.
  • Sugiura N; Department of Gastroenterology, Japan Community Health Care Organization Chiba Hospital, Chiba-shi, Chiba 260-8710, Japan.
  • Mizumoto H; Department of Gastroenterology, Funabashi Municipal Medical Center, Funabashi, Chiba 273-8588, Japan.
  • Azemoto R; Department of Gastroenterology, Kimitsu Chuo Hospital, Kimitsu, Chiba 292-8535, Japan.
  • Kato K; Department of Gastroenterology, Japan Community Health Care Organization Funabashi Central Hospital, Funabashi, Chiba 273-8556, Japan.
  • Shimada H; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Oncol Lett ; 24(4): 367, 2022 Oct.
Article en En | MEDLINE | ID: mdl-36238856

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2022 Tipo del documento: Article País de afiliación: Japón